Trial Profile
Double the Dose of Clopidogrel or Switch to Prasugrel to Antagonize Proton Pump Inhibitor Interaction. A Prospective, Mono-center, Placebo- and Active Treatment-controlled, Randomized, Cross Over Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Lansoprazole (Primary) ; Aspirin; Prasugrel
- Indications Cardiovascular disorders; Coronary artery disease; Embolism and thrombosis; Gastrointestinal disorders
- Focus Pharmacodynamics; Pharmacogenomic
- Acronyms DOSAPI
- 03 Jul 2012 Actual patient number (82) added as reported by ClinicalTrials.gov.
- 03 Jul 2012 Actual end date (Jul 2012) added as reported by ClinicalTrials.gov.
- 03 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.